74.48
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CTVA?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$73.24
Offen:
$73.96
24-Stunden-Volumen:
3.40M
Relative Volume:
0.96
Marktkapitalisierung:
$48.81B
Einnahmen:
$16.83B
Nettoeinkommen (Verlust:
$1.14B
KGV:
45.41
EPS:
1.64
Netto-Cashflow:
$2.10B
1W Leistung:
+0.38%
1M Leistung:
+7.73%
6M Leistung:
+29.55%
1J Leistung:
+38.70%
Corteva Inc Stock (CTVA) Company Profile
Firmenname
Corteva Inc
Sektor
Branche
Telefon
(833) 267-8382
Adresse
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Vergleichen Sie CTVA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CTVA
Corteva Inc
|
74.44 | 48.81B | 16.83B | 1.14B | 2.10B | 1.64 |
![]()
NTR
Nutrien Ltd
|
58.05 | 29.17B | 25.68B | 527.00M | 839.00M | 1.07 |
![]()
CF
Cf Industries Holdings Inc
|
90.80 | 14.93B | 6.13B | 1.34B | 1.86B | 7.59 |
![]()
MOS
Mosaic Company
|
35.23 | 10.81B | 11.06B | 367.80M | 212.50M | 1.16 |
![]()
ICL
Icl Group Ltd
|
6.795 | 8.61B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-31 | Hochstufung | Argus | Hold → Buy |
2025-03-13 | Eingeleitet | Goldman | Buy |
2024-10-23 | Eingeleitet | Citigroup | Buy |
2024-10-16 | Hochstufung | BofA Securities | Neutral → Buy |
2024-08-07 | Herabstufung | Argus | Buy → Hold |
2024-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
2024-03-01 | Eingeleitet | Wolfe Research | Outperform |
2024-02-12 | Hochstufung | Loop Capital | Hold → Buy |
2024-02-02 | Hochstufung | Exane BNP Paribas | Underperform → Neutral |
2023-11-27 | Herabstufung | Berenberg | Buy → Hold |
2023-11-14 | Herabstufung | Barclays | Overweight → Equal Weight |
2023-10-20 | Hochstufung | Oppenheimer | Perform → Outperform |
2023-09-05 | Hochstufung | UBS | Neutral → Buy |
2023-07-25 | Herabstufung | Redburn | Buy → Neutral |
2023-06-28 | Eingeleitet | Canaccord Genuity | Buy |
2023-05-22 | Hochstufung | Vertical Research | Hold → Buy |
2023-04-06 | Eingeleitet | Oppenheimer | Perform |
2023-01-19 | Eingeleitet | Wells Fargo | Overweight |
2023-01-11 | Hochstufung | BofA Securities | Underperform → Neutral |
2022-11-16 | Herabstufung | UBS | Buy → Neutral |
2022-11-15 | Herabstufung | Loop Capital | Buy → Hold |
2022-08-08 | Hochstufung | JP Morgan | Neutral → Overweight |
2022-08-08 | Hochstufung | ROTH Capital | Neutral → Buy |
2022-07-14 | Eingeleitet | Credit Suisse | Outperform |
2022-06-01 | Eingeleitet | Barclays | Overweight |
2022-05-06 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-04-14 | Hochstufung | Loop Capital | Hold → Buy |
2022-04-14 | Herabstufung | Vertical Research | Buy → Hold |
2022-01-31 | Hochstufung | Redburn | Neutral → Buy |
2021-10-18 | Herabstufung | Loop Capital | Buy → Hold |
2021-10-13 | Eingeleitet | Mizuho | Buy |
2021-10-08 | Eingeleitet | ROTH Capital | Buy |
2021-09-01 | Eingeleitet | Berenberg | Buy |
2021-08-09 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
2021-05-10 | Herabstufung | BofA Securities | Buy → Underperform |
2021-04-19 | Hochstufung | Loop Capital | Hold → Buy |
2021-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
2021-02-05 | Bestätigt | Monness Crespi & Hardt | Sell |
2020-12-18 | Herabstufung | Susquehanna | Positive → Neutral |
2020-12-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
2020-11-10 | Hochstufung | Argus | Hold → Buy |
2020-10-19 | Hochstufung | BofA Securities | Neutral → Buy |
2020-10-19 | Herabstufung | Exane BNP Paribas | Outperform → Underperform |
2020-08-11 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
2020-08-10 | Herabstufung | BofA Securities | Buy → Neutral |
2020-07-13 | Hochstufung | BofA Securities | Underperform → Buy |
2020-06-26 | Eingeleitet | Cleveland Research | Neutral |
2020-06-16 | Hochstufung | Vertical Research | Hold → Buy |
2020-06-08 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
2020-05-11 | Herabstufung | BofA/Merrill | Neutral → Underperform |
2020-04-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
2020-04-17 | Hochstufung | Loop Capital | Sell → Hold |
2020-04-01 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
2020-03-31 | Hochstufung | Susquehanna | Neutral → Positive |
2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
2020-03-19 | Hochstufung | Edward Jones | Hold → Buy |
2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
2020-03-10 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
Alle ansehen
Corteva Inc Aktie (CTVA) Neueste Nachrichten
Micropep and Corteva Announce Multi-Year Research Collaboration to Advance Sustainable Biocontrol Solutions - BioSpace
From Weaver Seed Co. to Pioneer to Corteva Agriscience, Grand Rapids plant celebrates 50-year history - BG Independent News
Micropep and Corteva Launch Multi-Year Partnership to Develop Sustainable Biocontrol Solutions - AgriBusiness Global
Corteva, Micropep Enter Multiyear Deal to Develop Peptide-Based Biofungicides - MarketScreener
Micropep and Corteva partner on peptide-based crop protection By Investing.com - Investing.com Nigeria
Micropep and Corteva partner on peptide-based crop protection - Investing.com Australia
Corteva (CTVA) Partners with Micropep for Innovative Biocontrol Solutions | CTVA Stock News - GuruFocus
Micropep and Corteva Announce Multi-Year Research Collaboration to Advance Sustainable Biocontrol Solutions | CTVA Stock News - GuruFocus
Corteva Secures Exclusive Rights to Revolutionary AI-Driven Peptide Technology for Sustainable Agriculture - Stock Titan
Corteva (NYSE:CTVA) stock performs better than its underlying earnings growth over last five years - simplywall.st
Micropep and Corteva partner to accelerate growth of peptide-based biocontrol solutions - AgFunderNews
Promising Agriculture Stocks To Watch TodayJune 17th - MarketBeat
Corteva at Wolfe Research Conference: Strategic Growth and Challenges By Investing.com - Investing.com South Africa
Corteva at Wolfe Research Conference: Strategic Growth and Challenges - Investing.com
Transcript : Corteva, Inc. Presents at Wolfe Research 2nd Annual Materials of the Future Conference, Jun-17-2025 12 - MarketScreener
Corteva stock hits all-time high at 74.2 USD - Investing.com
Corteva stock hits all-time high at 74.2 USD By Investing.com - Investing.com Canada
Morgan Stanley Adjusts Price Target on Corteva to $84 From $71, Maintains Overweight Rating - marketscreener.com
Crop Protection Chemicals Market Size 2025 Emerging Demands, - openPR.com
Corteva Stock: Is CTVA Outperforming the Basic Materials Sector? - MSN
Phytoform and Corteva partner on AI to boost disease resistance in corn - AgFunderNews
Here's How Much $1000 Invested In Corteva 5 Years Ago Would Be Worth Today - Benzinga
Forage Seed MarketGlobal Growth in Livestock and Dairy - openPR.com
Corteva Stock: Is CTVA Outperforming The Basic Materials Sector? - Barchart.com
Sustainable Agriculture Market Booms as Eco-Friendly Farming - openPR.com
Corteva to Participate in Wolfe’s Materials of the Future Conference - Krishak Jagat
Corteva to Participate in Wolfe's Materials of the Future Conference - Eastern Progress
United States Biopesticides Market Size, Insights 2031 by Key - openPR.com
Corteva to Participate in Wolfe's Materials of the Future Conference | CTVA Stock News - GuruFocus
NBC Securities Inc. Purchases 1,867 Shares of Corteva, Inc. (NYSE:CTVA) - Defense World
Dicamba Market Is Booming So Rapidly with CAGR of 7.9% | Bayer AG, BASF SE, Corteva Agriosciences - Kalkine Media
Corteva stock soars to all-time high of $72.26 amid robust growth By Investing.com - Investing.com South Africa
Corteva stock soars to all-time high of $72.26 amid robust growth - Investing.com India
Mizuho Adjusts Price Target on Corteva to $80 From $72, Maintains Outperform Rating - marketscreener.com
Reviewing Corteva (NYSE:CTVA) and Green Thumb Industries (OTC:GTBIF) - Defense World
FMC and Corteva Partner to Expand Access to Fluindapyr Fungicide - MSN
Grand Rapids seed production facility marks 50 years with open house - BG Independent News
Jefferies Raises Price Target for Corteva (CTVA) to $92 | CTVA S - GuruFocus
Jefferies Raises Price Target for Corteva (CTVA) to $92 | CTVA Stock News - GuruFocus
Expert Outlook: Corteva Through The Eyes Of 11 Analysts - Benzinga
Corteva (CTVA) Upgraded to Positive Following Dealer Insights | CTVA Stock News - GuruFocus
Jefferies Increases Price Target for Corteva (CTVA) Amid Positive Outlook | CTVA Stock News - GuruFocus
Jefferies raises Corteva stock price target citing growth potential By Investing.com - Investing.com South Africa
Jefferies raises Corteva stock price target citing growth potential - Investing.com India
Jefferies Adjusts Price Target on Corteva to $92 From $80, Maintains Buy Rating - marketscreener.com
Two Sigma Investments LP Cuts Stake in Corteva, Inc. (NYSE:CTVA) - Defense World
DuPont, Chemours and Corteva Will Pay Ohio $110 Million in Settlement Over “Forever” Chemicals - Cleveland Scene
FMC Stock Rises on New Partnership with Corteva - GuruFocus
Corteva (NYSE:CTVA) Partners With FMC To Expand Fluindapyr Fungicide In U.S. Markets - Yahoo
Corteva Stock Is Blooming and New Highs Are in Sight - The Globe and Mail
Talking Turf Weeds 14: Talking branded and generic with Justin Stewart - Golf Course Industry
Finanzdaten der Corteva Inc-Aktie (CTVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Corteva Inc-Aktie (CTVA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
FUERER CORNEL B | See Remarks |
May 13 '25 |
Sale |
68.06 |
55,242 |
3,759,771 |
101,641 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):